Wegovy prescribed online — FDA-approved for chronic weight management
Wegovy is the brand name for semaglutide approved specifically for chronic weight management in adults with obesity or overweight with comorbidities. Weekly injection, average ~15% body weight loss at one year, comprehensive clinician support.
What Wegovy is
Wegovy (semaglutide 2.4 mg weekly) received FDA approval in 2021 for chronic weight management in adults with BMI 30+ or BMI 27+ with at least one weight-related comorbidity. It was the first medication in a generation to demonstrate consistent ~15% average body weight loss in randomized trials — the STEP series.
In 2024, the FDA expanded Wegovy's indication based on the SELECT trial results, which showed that semaglutide reduced major adverse cardiovascular events by 20% in adults with obesity and pre-existing cardiovascular disease. This was a landmark expansion — semaglutide is now positioned as cardiovascular preventive therapy in addition to weight management.
Wegovy and compounded semaglutide contain the same active molecule. Wegovy is the brand-name product manufactured by Novo Nordisk; compounded semaglutide is prepared by licensed U.S. compounding pharmacies. HealifyNow can prescribe either, with the choice typically driven by cost, availability, and clinical judgment.
Wegovy eligibility
BMI 30+
Primary indication for Wegovy.
BMI 27+ with comorbidities
Hypertension, prediabetes, dyslipidemia, sleep apnea, fatty liver.
Cardiovascular disease + obesity
SELECT trial expanded indication — Wegovy is now positioned as cardiovascular prevention in this population.
Adolescents 12+
Wegovy is approved for adolescents with obesity, the first GLP-1 with this indication.
How HealifyNow makes it simple
From your first message to your medication arriving at your door — clinician-guided, every step.
Schedule your free visit
A care team member meets with you to understand your goals, medical history, and treatment preferences. The first visit is no-cost and no-commitment — we want you to be confident before moving forward.
Meet your licensed clinician
Connect by secure video or phone with a U.S.-licensed physician or nurse practitioner who reviews your full picture — labs, prior treatments, current medications, and lifestyle — and decides what is clinically appropriate.
Receive your prescription if appropriate
If your clinician determines treatment is right for you, they issue a prescription that goes to a licensed U.S. pharmacy. We coordinate discreet shipping, or you can fill it locally. Follow-up visits are built in.
How Wegovy works
Wegovy works through GLP-1 receptor activation across multiple tissues: appetite reduction in the hypothalamus, slowed gastric emptying, improved insulin response, and direct cardiovascular protective effects. See our semaglutide page for the detailed mechanism.
The 2.4 mg target dose is higher than Ozempic's diabetes dosing (up to 2 mg) — which is the dose at which clinical trials demonstrated the consistent ~15% weight loss. Lower doses produce lower weight loss; higher doses haven't been shown to add benefit and increase side effects.
The titration schedule (16-week ramp-up to 2.4 mg) exists to minimize GI side effects. Members who climb too fast often experience nausea that pushes them off therapy. Slower titration in some members may improve tolerance.
Important safety information
Your clinician will review every relevant detail with you. Here are the most important points to know up front.
GI side effects
Most common during titration. Slow ramp-up and dietary adjustments help.
Thyroid cancer history
Personal or family history of medullary thyroid carcinoma rules out use.
Pregnancy contraindication
Discontinue at least 2 months before planned conception.
Gallbladder disease
Rapid weight loss increases gallstone risk. Tell your clinician about gallbladder history.
All medications must be prescribed by a licensed provider based on medical necessity. Treatment is not suitable for everyone. Results may vary.
How to use Wegovy
Wegovy is dispensed as single-dose pre-filled pens. One pen per week, injected subcutaneously into abdomen, thigh, or upper arm. Rotate sites each week.
Standard titration: 0.25 mg for 4 weeks, then 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg. Total 16-20 weeks to reach maintenance dose. Your clinician personalizes the speed based on your tolerance.
Refrigerate unused pens. Once in use, can stay at room temperature for up to 28 days. Dispose of needles in a sharps container.
Lab and weight checks at intervals through the first year; ongoing follow-up at quarterly to biannual cadence after stable.
Quick eligibility tool
Get a fast read on whether this is worth a deeper conversation.
120k+
Patients served across the U.S.
96%
Member satisfaction with care team
4.8★
Average review rating
3 days
From visit to medication shipment
Why patients choose HealifyNow
We built HealifyNow because telehealth done badly is everywhere — and telehealth done right still feels rare. Here is what makes us different.
Easy Online Process
No waiting rooms, no faxed forms, no insurance hoops. Quick consults, simple intake, prescriptions handled digitally.
U.S.-Licensed Clinicians
Real physicians, nurse practitioners, and specialists licensed in your state. Not chatbots, not offshore call centers.
Discreet Home Delivery
Medications ship from licensed U.S. pharmacies in plain packaging. Most orders arrive in 2-5 business days.
Support That Answers
Reach a real human seven days a week. Most messages get a clinical reply within a few hours, not days.
The physicians behind your care
HealifyNow prescriptions are reviewed and authorized by independently licensed physicians — real doctors with real credentials from top medical institutions in the United States.
Dr. Benjamin H. Krasne is a board-certified physician whose deep understanding of human physiology and clinical precision positions him as a powerful force in longevity and metabolic health. A graduate of the University of Miami Miller School of Medicine, Dr. Krasne completed his residency at Jackson Memorial Hospital — one of the nation's foremost academic medical centers — where he developed an advanced mastery of how the body responds to stress, recovery, and optimization at the physiological level.
Board-certified by the American Board of Anesthesiology, Dr. Krasne brings a uniquely rigorous, science-driven lens to longevity medicine and weight management. His expertise in pharmacology, pain physiology, and metabolic responses gives him a sophisticated foundation for understanding the biological mechanisms that drive aging, inflammation, hormonal imbalance, and weight gain — and, more importantly, how to reverse them.
Dr. Krasne believes sustainable weight loss and healthy aging are not the result of quick fixes, but of precise, personalized interventions rooted in clinical science.
Dr. Johnathan Chance Miller is a physician and holistic medicine practitioner dedicated to helping patients live longer, healthier, and more vibrant lives. Dr. Miller earned his medical degree from Columbia University College of Physicians and Surgeons in New York City and completed his internship and residency at Washington University in Saint Louis — institutions renowned for producing some of the country's most innovative medical minds.
A former collegiate athlete and rugby team captain, Dr. Miller understands firsthand the relationship between physical performance, nutrition, and long-term wellness. This lived experience drives his commitment to optimizing metabolic function, body composition, and healthspan for his patients.
As a physician at the forefront of holistic medicine, Dr. Miller blends cutting-edge science with personalized lifestyle strategies to address the root causes of weight gain, metabolic dysfunction, and accelerated aging.
Dr. Vanessa Niles is a board-certified Obstetrician-Gynecologist and Fellow of the American College of Obstetricians and Gynecologists (FACOG) with more than 40 years of experience in Obstetrics and Gynecology. She earned her Doctor of Medicine degree from Meharry Medical College and completed her residency training in Obstetrics and Gynecology at Brookdale University Hospital and Medical Center.
She has a well-established and respected history of worldwide medical collaboration, research, philanthropy, and outreach. She was appointed by former President Bush as an International Medical Ambassador, reflecting her global commitment to women's health and medical excellence.
Throughout her distinguished career, Dr. Niles has remained a passionate advocate for her patients, combining clinical expertise with a holistic, compassionate approach to care.
What members are saying
Real people, real results. Names and details published with permission.
"Started Wegovy at 248 lbs, BMI 38. Twelve months later: 197 lbs, BMI 30. Knee pain gone, off two blood pressure meds. The food noise quieted within three weeks and that alone was life-changing."
"Tried every diet for 20 years. Wegovy is the first thing that actually worked. Down 41 lbs in 8 months. The hunger I'd been fighting since adolescence finally stopped."
"HealifyNow's process was simple. Labs, video visit, prescription. Down 28 lbs in 5 months on Wegovy. Felt supported the entire way."
Frequently asked questions
HealifyNow makes it easy to move forward with confidence. Here are the answers to what people ask us most.
How is Wegovy different from Ozempic?
+
Same active ingredient (semaglutide); different dose (2.4 mg vs up to 2 mg) and different FDA-approved use (weight management vs diabetes).
Is Wegovy worth the cost compared to compounded semaglutide?
+
Wegovy is the brand-name, FDA-approved product. Compounded semaglutide contains the same molecule from licensed compounding pharmacies and is often substantially less expensive. Choice depends on your situation; your clinician will discuss.
How much weight will I lose on Wegovy?
+
STEP-1 trial averaged 14.9% at 68 weeks. Individual results vary widely; about 1 in 3 loses 20%+, about 1 in 10 loses less than 5%.
Will my insurance cover Wegovy?
+
Coverage is mixed. Some commercial plans cover Wegovy with prior auth and significant cost-sharing; many do not. Medicare typically does not cover weight-loss medications. We can help you check.
How long should I stay on Wegovy?
+
Obesity is a chronic condition. Long-term use is typical for sustained results. Many members continue indefinitely at a maintenance dose.
What happens if I stop Wegovy?
+
Weight regain over 12-18 months is common (research shows about two-thirds of weight returns on average). This is consistent across all weight loss medications.
Can I get Wegovy for cardiovascular protection without obesity?
+
The current FDA indication still requires BMI 27+ with comorbidities or BMI 30+. Cardiovascular protection is an additional benefit within that population.
Is Wegovy available for adolescents?
+
Yes — FDA approved for ages 12+ in 2022 for adolescents with BMI in the obesity range. Requires pediatric-experienced clinician evaluation.
Get Wegovy prescribed properly.
Book a free consultation. Real evaluation, transparent costs, full clinical support.